Skip to main content
36°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
29
30
Next >
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
Biotech
COLL
TNDM
From
Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
Tickers
AGIO
AZN
BMY
GMED
Tags
News
AZN
GSK
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
ANY
Market News
Benzinga
From
Benzinga
3 Top Biotech Stocks to Buy for the Long Haul
February 17, 2022
Tickers
MRNA
REGN
VRTX
Tags
VRTX
Recent Press Releases
REGN
From
Motley Fool
5 Value Stocks To Watch In The Healthcare Sector
February 14, 2022
Tickers
FONR
QURE
REGN
SURF
Tags
BZI/VS
Market News
Benzinga
From
Benzinga
Lilly's Antibody Receives FDA Emergency Use Nod For Mild-To-Moderate COVID-19
February 14, 2022
Tickers
ABCL
LLY
REGN
Tags
ABCL
COVID/19 Coronavirus
REGN
From
Benzinga
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
Tickers
GSK
ICPT
LLY
REGN
Tags
LLY
Market News
XBI
From
Motley Fool
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
February 10, 2022
Tickers
ALNY
NVS
REGN
Tags
Briefs
Earnings
General
From
Benzinga
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
Tickers
REGN
SNY
Tags
atopic dermatitis
FDA
REGN
From
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Tickers
AGLE
ALNY
ALVR
ARMP
Tags
Small Cap
ILMN
FDA
From
Benzinga
10 Biggest Price Target Changes For Tuesday
February 08, 2022
Tickers
CRNC
DDOG
MCK
REGN
Tags
Price Target
CRNC
DDOG
From
Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
MRK
GSK
PFE
From
MarketWatch
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
MRK
Cathie Wood
REGN
From
Benzinga
Could This New Indication Create a Blockbuster for Pfizer?
February 05, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
ABBV
PFE
Market News
From
Motley Fool
This Will Put a Big Dent in Eli Lilly's and Regeneron's Sales This Year
February 04, 2022
Tickers
LLY
PFE
REGN
Tags
Recent Press Releases
REGN
PFE
From
Motley Fool
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
VIR
LLY
GILD
From
MarketWatch
Regeneron's Q4 Sales, Profits More Than Double With Boost From COVID-19 Treatment Sales
February 04, 2022
Tickers
REGN
Tags
Benzinga
Health Care
Market News
From
Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
Tickers
AKRO
BMY
GLPG
IBB
Tags
IRMD
SNY
Penny Stocks
From
Benzinga
Recap: Regeneron Pharmaceuticals Q4 Earnings
February 04, 2022
Tickers
REGN
Tags
News
BZI/Recaps
Benzinga
From
Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
Tickers
ADNT
AON
APD
BBU
Tags
Earnings
BEP
Pre/Market Outlook
From
Benzinga
Earnings Preview For Regeneron Pharmaceuticals
February 03, 2022
Tickers
REGN
Tags
BZI/EP
REGN
Market News
From
Benzinga
What This FDA News Could Mean for Pfizer
February 01, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
PFE
Market News
GILD
From
Motley Fool
Should Investors Sell Eli Lilly After This Recent Regulatory News?
February 01, 2022
Tickers
LLY
REGN
Tags
Market News
LLY
Recent Press Releases
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
February 01, 2022
Tickers
AGIO
AMYT
ATXI
CTIC
Tags
LLY
Market News
PFE
From
Benzinga
3 Biotech Stocks That Could Boom or Bust in Q1
February 01, 2022
Tickers
OCGN
REGN
VRTX
Tags
NASDAQ:VRTX,NASDAQ:REGN,NASDAQ:OCGN
Hot Stocks
Market News
From
InvestorPlace
5 Things To Expect This Week
January 31, 2022
Tickers
AAPL
AMD
AMZN
APPS
Tags
Market Insight, Financial Articles
ALICE/USD
FB
From
InvestorPlace
Analyst Ratings For Regeneron Pharmaceuticals
January 31, 2022
Tickers
REGN
Tags
REGN
Market News
Analyst Ratings
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
MRNA
News
General
From
Benzinga
CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation
January 31, 2022
Tickers
REGN
SNY
Tags
Benzinga
Health Care
Market News
From
Benzinga
Market corrections are good buying opportunities, says Goldman Sachs — but only when this happens
January 31, 2022
Tickers
CTRA
LPX
MRNA
REGN
Tags
SWKS
SPX
CTRA
From
MarketWatch
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.